Dvision Network to Host “Live Debate” on Cryptocurrency Legislation Organized by Korean National Assembly
SEOUL, SOUTH KOREA / ACCESSWIRE / August 12, 2021 / The blockchain-based metaverse Dvision Network…
Month: August 2021
Neutrisci Provides Update on Tabletz Developments
VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / NeutriSci International Inc. (“NeutriSci” or the…
Crypto Poor Boy Joins Hands With Blockchain Press Media to Empower their Platform & Community
DUBAI, UAE / ACCESSWIRE / August 12, 2021 / The Blockchain Press Media (BPM) has…
ZincX Resources Announces Commencement of Trading on the OTCQB Market
VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / ZincX Resources Corp. (“ZincX” or the…
EastCoal Announces Private Placement, Appointment of A New Director and Name Change
VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / EastCoal Inc (TSX-V:ECX) (“EastCoal” or the…
SpendHQ Adds New Category Management Module for Full Spend Intelligence
ATLANTA, GA / ACCESSWIRE / August 12, 2021 / SpendHQ, the industry-leading spend analytics platform,…
Grupo Clarín Announces First Half and Second Quarter 2021 Results
BUENOS AIRES, ARGENTINA / ACCESSWIRE / August 11, 2021 / Grupo Clarín S.A. (“Grupo Clarín”…
Logicalis recognised as a Leader in the IDC MarketScape on Worldwide Network Consulting Services 2021 Vendor Assessment
London, U.K, 12 August 2021 — Logicalis, an international IT solutions and managed service provider,…
Novozymes delivers strong Q2 results and narrows full-year guidance to the high-end of the range
Novozymes delivered 9% organic sales growth in the second quarter and 6% organic sales growth…
Interim report for 1H 2021
Please read the full announcement in the attached PDF Attachment 2021_41_Q22021_CompanyAnnouncement
Ultimovacs Announces Further Positive Topline Results from Phase I UV1 Cancer Vaccine Combination Study in Metastatic Melanoma
Cohort 2 showed 60% objective response rate, 30% complete response rate 90% overall survival rate…
Ultimovacs Announces Further Positive Topline Results from Phase I UV1 Cancer Vaccine Combination Study in Metastatic Melanoma
Cohort 2 showed 60% objective response rate, 30% complete response rate 90% overall survival rate…
Novozymes reaches a strategic milestone in the implementation of its strategy with a significant entry into Advanced Protein Solutions
Please read the full announcement in the attached PDF Attachment 2021_40_CompanyAnnouncement
Fulcrum Therapeutics Announces Pricing of $125 Million Public Offering of Common Stock
CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage…
MDxHealth to Present First Half 2021 Financial Results and Corporate Update on August 26
Company to Host Conference Call and Live Q&A Session, August 26, 2021, at 10:00am PT/ 1:00pm…
Osmotica Pharmaceuticals plc to Provide Second Quarter 2021 Business and Financial Update on August 16, 2021
BRIDGEWATER, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or…
Surrozen Debuts as Publicly Traded Leader in Wnt Biology and Tissue Regeneration
Common stock and warrants to commence trading on Nasdaq on August 12, 2021 under the…
Shattuck Labs Reports Second Quarter 2021 Financial Results and Upcoming Phase 1 Dose Escalation Data for SL-172154 and SL-279252
– Announced submission of abstracts for the initial Phase 1 dose-escalation data from both SL-172154…
ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Ophthalmology Virtual Conference
LEIDEN, Netherlands & CAMBRIDGE, Mass., Aug. 11, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
NRx Pharmaceuticals to Report Second Quarter 2021 Results August 16, 2021
–Company to Host Conference Call August 17, 2021 at 8:30AM ET– RADNOR, Pa., Aug. 11,…